This company has been acquired
Resumen de acción NTUS
Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 3/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Recompensas
Análisis de riesgos
Competidores de Natus Medical Incorporated
Historial de precios y rendimiento
Historical stock prices | |
---|---|
Current Share Price | US$32.96 |
52 Week High | US$33.93 |
52 Week Low | US$20.90 |
Beta | 0.23 |
1 Month Change | 2.08% |
3 Month Change | -1.38% |
1 Year Change | 34.37% |
3 Year Change | 23.22% |
5 Year Change | -8.06% |
Change since IPO | 128.10% |
Noticias y actualizaciones recientes
Recent updates
Novanta to replace Six Flags Entertainment in S&P MidCap 400, Six Flags to replace Natus Medical in S&P SmallCap 600
Jul 22Some Investors May Be Worried About Natus Medical's (NASDAQ:NTUS) Returns On Capital
Mar 04Some Investors May Be Worried About Natus Medical's (NASDAQ:NTUS) Returns On Capital
Nov 08We Like Natus Medical's (NASDAQ:NTUS) Earnings For More Than Just Statutory Profit
Aug 13Does Natus Medical (NASDAQ:NTUS) Have A Healthy Balance Sheet?
Aug 02We Think Shareholders Are Less Likely To Approve A Pay Rise For Natus Medical Incorporated's (NASDAQ:NTUS) CEO For Now
Jun 10Breakeven Is Near for Natus Medical Incorporated (NASDAQ:NTUS)
May 05Is Natus Medical (NASDAQ:NTUS) Using Debt Sensibly?
Feb 15Breakeven Is Near for Natus Medical Incorporated (NASDAQ:NTUS)
Jan 11Reflecting on Natus Medical's (NASDAQ:NTUS) Share Price Returns Over The Last Five Years
Dec 07Rentabilidad de los accionistas
NTUS | US Medical Equipment | Mercado US | |
---|---|---|---|
7D | 0.8% | 1.6% | 1.0% |
1Y | 34.4% | -1.4% | 21.9% |
Rentabilidad vs. Industria: NTUS exceeded the US Medical Equipment industry which returned -23.9% over the past year.
Rentabilidad vs. Mercado: NTUS exceeded the US Market which returned -15.4% over the past year.
Volatilidad de los precios
NTUS volatility | |
---|---|
NTUS Average Weekly Movement | 2.2% |
Medical Equipment Industry Average Movement | 7.3% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.8% |
10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: NTUS has not had significant price volatility in the past 3 months.
Volatilidad a lo largo del tiempo: NTUS's weekly volatility (2%) has been stable over the past year.
Acerca de la empresa
Fundada | Empleados | CEO | Página web |
---|---|---|---|
1987 | 1,400 | Tom Sullivan | www.natus.com |
Resumen de fundamentos de Natus Medical Incorporated
Estadísticas fundamentales de NTUS | |
---|---|
Capitalización bursátil | US$1.13b |
Beneficios(TTM) | US$12.68m |
Ingresos (TTM) | US$478.30m |
89.0x
Ratio precio-beneficio (PE)2.4x
Ratio precio-ventas (PS)¿Está NTUS sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
Cuenta de resultados (TTM) de NTUS | |
---|---|
Ingresos | US$478.30m |
Coste de los ingresos | US$199.61m |
Beneficio bruto | US$278.70m |
Otros gastos | US$266.01m |
Beneficios | US$12.68m |
Últimos beneficios comunicados
Mar 31, 2022
Próxima fecha de beneficios
n/a
Beneficios por acción (BPA) | 0.37 |
Margen bruto | 58.27% |
Margen de beneficio neto | 2.65% |
Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado NTUS a largo plazo?
Ver rendimiento histórico y comparativa